CK1-IN-1

CAS No. 1784751-20-7

CK1-IN-1( PUN51207 )

Catalog No. M20134 CAS No. 1784751-20-7

CK1-IN-1 compound 1c reported in patent WO2015119579A1 is a casein kinase 1 (CK1) inhibitor. It has IC50s of 15 nM 16 nM 73 nM for CK1δ and CK1ε p38σ MAPK respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 103 In Stock
2MG 56 In Stock
5MG 93 In Stock
10MG 155 In Stock
25MG 306 In Stock
50MG 461 In Stock
100MG 693 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CK1-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    CK1-IN-1 compound 1c reported in patent WO2015119579A1 is a casein kinase 1 (CK1) inhibitor. It has IC50s of 15 nM 16 nM 73 nM for CK1δ and CK1ε p38σ MAPK respectively.
  • Description
    CK1-IN-1 compound 1c reported in patent WO2015119579A1 is a casein kinase 1 (CK1) inhibitor. It has IC50s of 15 nM 16 nM 73 nM for CK1δ and CK1ε p38σ MAPK respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PUN51207
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Casein Kinase
  • Recptor
    CK1|p38σ MAPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1784751-20-7
  • Formula Weight
    383.39
  • Molecular Formula
    C24H15F2N3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 60 mg/mL (156.5 mM); Water: Insoluble
  • SMILES
    Fc1ccc(cc1)-c1nc([nH]c1-c1ccncc1)-c1ccc2ccccc2c1F
  • Chemical Name
    Pyridine 4-[2-(1-fluoro-2-naphthalenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Filip LACOet al. 245-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis. WO2015119579A1.
molnova catalog
related products
  • CK2/ERK8-IN-1

    CK2/ERK8-IN-1 is a dual inhibitor of casein kinase 2 (CK2) (Ki: 0.25 μM) and ERK8 (IC50s: 0.50 μM) with pro-apoptotic efficacy.

  • Casein kinase 1δ-IN-...

    Casein kinase 1δ-IN-8 is an inhibitor of casein kinase 1δ and is used to treat neurodegenerative diseases such as Alzheimer's disease type.

  • CK2-IN-4

    CK2-IN-4 is a protein kinase (CK2) inhibitor with an IC50 value of 8.6 μM. CK2-IN-4 has potential anticancer ah and anti-inflammatory activity for the study of viral infections and glomerulonephritis diseases.